Search

Your search keyword '"Canmei Zhong"' showing total 2 results
Start Over Author "Canmei Zhong" Journal cancer medicine
2 results on '"Canmei Zhong"'

1. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity‐matched analysis of Surveillance, Epidemiology, and End Results database

Author

Qiuyan Lin, Xiaoquan Huang, Canmei Zhong, Tiancheng Luo, Xiaoqing Zeng, and Shiyao Chen

Subjects
hepatocellular carcinoma, major vascular invasion, propensity score‐match, radiotherapy, Surveillance, Epidemiology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Objectives Hepatocellular carcinoma (HCC) associated with major vascular invasion is an advanced stage disease with an extremely poor prognosis and low survival rate. Our study evaluated the survival benefit of radiotherapy (RT) in HCC patients with major vascular invasion through Surveillance, Epidemiology, and End Results database. Methods We analyzed 3181 HCC patients with major vascular invasion cases diagnosed from 2004 to 2013. Patients (N = 308) who underwent RT and patients (N = 2873) who did not receive RT were compared. We successfully analyzed patients using propensity score matching (PSM). Kaplan‐Meier and Cox‐regression analyses were applied to assess prognosis. Results The median survival time in radiation‐treated group was longer compared to the control group (7 months vs 3 months; P

Published
2019
Full Text
View/download PDF

2. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database

Author

Canmei Zhong, Shiyao Chen, Qiuyan Lin, Xiaoquan Huang, Tiancheng Luo, and Xiaoqing Zeng

Subjects
0301 basic medicine, Male, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, Epidemiology, and End Results, Subgroup analysis, Kaplan-Meier Estimate, Lower risk, Gastroenterology, propensity score‐match, major vascular invasion, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Surveillance, Epidemiology, and End Results, Humans, Radiology, Nuclear Medicine and imaging, Propensity Score, Survival rate, radiotherapy, Aged, Proportional Hazards Models, Original Research, Surveillance, Neovascularization, Pathologic, business.industry, Liver Neoplasms, Clinical Cancer Research, hepatocellular carcinoma, medicine.disease, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Propensity score matching, Cohort, Female, business, SEER Program
Abstract

Objectives Hepatocellular carcinoma (HCC) associated with major vascular invasion is an advanced stage disease with an extremely poor prognosis and low survival rate. Our study evaluated the survival benefit of radiotherapy (RT) in HCC patients with major vascular invasion through Surveillance, Epidemiology, and End Results database. Methods We analyzed 3181 HCC patients with major vascular invasion cases diagnosed from 2004 to 2013. Patients (N = 308) who underwent RT and patients (N = 2873) who did not receive RT were compared. We successfully analyzed patients using propensity score matching (PSM). Kaplan‐Meier and Cox‐regression analyses were applied to assess prognosis. Results The median survival time in radiation‐treated group was longer compared to the control group (7 months vs 3 months; P

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results